Distinguished in Atypical Teratoid Rhabdoid Tumor (ATRT)

Lucie Cousin-Lafay

Calgary, AB, CA 
Distinguished in Atypical Teratoid Rhabdoid Tumor (ATRT)
Calgary, AB, CA 
OverviewLocationsClinical Research

Overview

Lucie Cousin-Lafay practices in Calgary, Canada. Ms. Cousin-Lafay is rated as a Distinguished expert by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). Her top areas of expertise are Medulloblastoma, Embryonal Tumor with Multilayered Rosettes, Rhabdoid Tumor, Atypical Teratoid Rhabdoid Tumor (ATRT), and Bone Marrow Transplant.

Her clinical research consists of co-authoring 76 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 4 articles in the study of Atypical Teratoid Rhabdoid Tumor (ATRT).

Gender
Female

Locations

Calgary, AB, Canada
Other Locations
Calgary, Canada
Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 2 Study of Trametinib for Patients With Pediatric Glioma or Plexiform Neurofibroma With Refractory Tumor and Activation of the MAPK/ERK Pathway.
A Phase 2 Study of Trametinib for Patients With Pediatric Glioma or Plexiform Neurofibroma With Refractory Tumor and Activation of the MAPK/ERK Pathway.
Enrollment Status: Active_not_recruiting
Publish Date: November 27, 2023
Intervention Type: Drug
Study Drug: Trametinib
Study Phase: Phase 2
A Phase II Study for the Treatment of Non-metastatic Nodular Desmoplastic Medulloblastoma in Children Less Than 4 Years of Age
A Phase II Study for the Treatment of Non-metastatic Nodular Desmoplastic Medulloblastoma in Children Less Than 4 Years of Age
Enrollment Status: Completed
Publish Date: January 09, 2023
Intervention Type: Drug, Other
Study Drugs: Carboplatin, Cyclophosphamide, Etoposide, Methotrexate, Vincristine Sulfate
Study Phase: Phase 2
View 1 Less Clinical Trial

76 Total Publications

A national modified Delphi consensus on the referral and management of NF1 plexiform neurofibroma.
A national modified Delphi consensus on the referral and management of NF1 plexiform neurofibroma.
Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Published: September 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Cousin-Lafay's expertise for a condition
ConditionClose
View All 16 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile